EBIT: Income before interest and taxes.
Jazz Pharmaceuticals PLC (JAZZ) had EBIT of $260.21M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$1.05B |
|
$215.06M |
|
$111.61M |
|
$943.36M |
|
$794.76M |
|
$260.21M |
|
$-59.40M |
|
$200.81M |
|
$200.81M |
|
$215.34M |
|
$215.06M |
|
$215.06M |
|
$215.34M |
|
|
EBIT |
$260.21M |
$425.44M |
|
61.41M |
|
63.17M |
|
$3.50 |
|
$3.42 |
|
| Balance Sheet Financials | |
$4.39B |
|
$176.42M |
|
$7.87B |
|
$12.26B |
|
$1.03B |
|
$6.08B |
|
$7.05B |
|
$8.08B |
|
$4.17B |
|
$-2.78B |
|
$4.17B |
|
60.44M |
|
| Cash Flow Statement Financials | |
$997.33M |
|
$-314.91M |
|
$28.79M |
|
$1.51B |
|
$2.22B |
|
$711.83M |
|
$177.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
0.59 |
|
1.47 |
|
89.42% |
|
24.67% |
|
24.67% |
|
-- |
|
19.03% |
|
20.39% |
|
$972.54M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.21 |
|
1.46 |
|
61.73 |
|
5.16% |
|
-7.74% |
|
1.75% |
|
2.10% |
|
$69.01 |
|
$15.39 |
|
$15.79 |
|